PGEN

Precigen, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$3.94

Market Cap

$1.18B

Beta

1.12

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+146.73%

EPS Growth (YoY)-100.00%

Revenue CAGR 3Y-28.87%

P/E Ratio0.0

PEG Ratio—

FCF Yield-7.64%

Debt / Equity0.24

Interest Coverage-28.6x

No credit card required

Already have an account? Sign in to view the full analysis for PGEN.